No effective conventional therapy for malignant pleural mesothelioma has yet been described. Radiotherapy does not increase median survival, but there is a palliative analgesic benefit. Chemotherapy with a different regimen in 182 patients led to a median survival time of 12 months. In comparison to an untreated historical group of 142 patients, there is an advantage in survival of 5 months. Additional surgical treatment has not prolonged the life expectancy. The percentage of long-time survivors was 5.5%.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
therapy malignant
8
malignant pleural
8
median survival
8
[conservative palliative
4
palliative therapy
4
pleural mesothelioma]
4
mesothelioma] effective
4
effective conventional
4
conventional therapy
4
pleural mesothelioma
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!